• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

People of Black and Asian ethnicity up to twice as likely to be infected with COVID-19 as those of White ethnicity

Nov 12, 2020

People of Black ethnicity are twice as likely to be infected with COVID-19 compared to those of White ethnicity, according to researchers at the Universities of Leicester and Nottingham, supported by the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre. The findings are published in EClinical Medicine by The Lancet today (Thursday 12 November 2020).

People from Asian backgrounds are also 1.5 times more likely to become infected with the virus compared to White individuals.

In the first meta-analysis of the effect of ethnicity on clinical outcomes in patients with COVID-19, which screened over 1500 articles, the research team pooled data from more than 18 million people who had taken part in 50 studies in the United Kingdom and United States of America. All the studies included in the analysis were published between 1 December 2019 and 31 August 2020 in peer-reviewed journals or as pre-prints waiting for peer-review.

All the patients included in the study who had COVID-19 were defined as such by a positive nasal swab test or clinical signs and symptoms of the virus, along with radiology and laboratory tests.
Researchers also found those of Asian ethnicities to be at higher risk of admission to an intensive therapy unit (ITU) and death. However, all studies investigating ITU admission that were included in the meta-analysis had not yet been peer-reviewed, and the risk of death was only of borderline statistical significance. This is in contrast to the strong evidence of increased risk of infection in Black and Asian ethnic groups.

Dr Manish Pareek, Associate Clinical Professor in Infectious Diseases at the University of Leicester, Consultant in Infectious Diseases at the University Hospitals of Leicester NHS Trust and a senior author on the paper, said: “Our findings suggest that the disproportionate impact of COVID-19 on Black and Asian communities is mainly attributable to increased risk of infection in these communities.

“Many explanations exist as to why there may be an elevated level of COVID-19 infection in ethnic minority groups, including the greater likelihood of living in larger household sizes comprised of multiple generations; having lower socioeconomic status, which may increase the likelihood of living in overcrowded households; and being employed in frontline roles where working from home is not an option.

Dr Shirley Sze, NIHR Academic Clinical Lecturer and Specialist Registrar in Cardiology at the University of Leicester, and a lead author of the paper, said: “The clear evidence of increased risk of infection amongst ethnic minority groups is of urgent public health importance – we must work to minimise exposure to the virus in these at-risk groups by facilitating their timely access to healthcare resources and target the social and structural disparities that contribute to health inequalities.”

Dr Daniel Pan, Specialist Registrar in Infectious Diseases at the University Hospitals of Leicester NHS Trust and an NIHR Clinical Academic Fellow at the University of Leicester is a lead author of the paper. He said: “Future papers must try to adjust for the risk of infection when looking at the risk of ITU admission and death in COVID-19 patients, in order for us to accurately assess the impact of ethnicity on an individual’s risk of death once they are infected”.

The paper, ‘Ethnicity and clinical outcomes in COVID-19: A Systematic Review and Meta-analysis’ is published in EClinical Medicine by The Lancet on 12 November 2020.

Ends

Category: Press ReleasesTag: BME, coronavirus, covid, News, Press Release

Sidebar

Recent News

Leicester health specialists receive NIHR prizes for excelling in their fields

Respiratory researcher awarded Asthma + Lung UK Junior Fellowship

Weight-loss drug users turn to social media over doctors for advice

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}